Dr Geraint Davies

Clinical Infection, Microbiology and Immunology


    Research Group Membership
    Research Grants
    • PanACEA Biomarker Extension Project (PANBIOME)
    • Randomised trial of high-dose rifampin in patients with new, smear-positive TB
    • Model-based preclinical development of anti-tuberculosis drug combinations (preDICT-TB)
    • Population pharmacokinetic-pharmacodynamic modelling to optimise treatments for HIV,TB and malaria
    • Modulation of TB-HIV drug interaction by host genetic influences
    • Wellcome Trust Clinical PhD Programme - Derek Sloan: Understanding mycobacterial persistence in sputum during treatment for tuberculosis
    • Investigation into the relationship between pharmacological and immunological responses to tuberculosis treatment and risk of early death
    • Adjunctive Rifampicin to Reduce Early mortality from Staphylococcus aureus bacteraemia: a multi-centre, randomised, double blind, placebo controlled trial (the ARREST trial).